- Home
- BLND vs INVA Comparison
BLND vs INVA Comparison
Compare BLND & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLND
- INVA
- Stock Information
- Founded
- BLND 2012
- INVA 1996
- Country
- BLND United States
- INVA United States
- Employees
- BLND N/A
- INVA N/A
- Industry
- BLND EDP Services
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- BLND Technology
- INVA Health Care
- Exchange
- BLND Nasdaq
- INVA Nasdaq
- Market Cap
- BLND 946.9M
- INVA 1.2B
- IPO Year
- BLND 2021
- INVA 2004
- Fundamental
- Price
- BLND $3.99
- INVA $18.28
- Analyst Decision
- BLND Buy
- INVA Buy
- Analyst Count
- BLND 8
- INVA 1
- Target Price
- BLND $4.86
- INVA N/A
- AVG Volume (30 Days)
- BLND 2.9M
- INVA 585.7K
- Earning Date
- BLND 03-13-2025
- INVA 02-27-2025
- Dividend Yield
- BLND N/A
- INVA N/A
- EPS Growth
- BLND N/A
- INVA 46.55
- EPS
- BLND N/A
- INVA 0.99
- Revenue
- BLND $156,715,000.00
- INVA $352,745,000.00
- Revenue This Year
- BLND $5.35
- INVA $16.20
- Revenue Next Year
- BLND $20.75
- INVA N/A
- P/E Ratio
- BLND N/A
- INVA $18.59
- Revenue Growth
- BLND N/A
- INVA 21.46
- 52 Week Low
- BLND $2.08
- INVA $14.33
- 52 Week High
- BLND $5.53
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- BLND 43.79
- INVA 50.49
- Support Level
- BLND $3.61
- INVA $18.66
- Resistance Level
- BLND $4.06
- INVA $19.06
- Average True Range (ATR)
- BLND 0.20
- INVA 0.35
- MACD
- BLND 0.06
- INVA 0.06
- Stochastic Oscillator
- BLND 61.38
- INVA 48.96
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.